Navigation Links
Assurex Health Appoints Chief Financial Officer and Payer Market Executive to Manage Rapid Growth in Personalized Medicine
Date:4/2/2013

MASON, Ohio, April 2, 2013 /PRNewswire/ -- AssureRx Health, Inc. today announced the appointment of Stephen A. Stamp as Senior Vice President & CFO and Jeffrey P. Bush as Vice President, Payer Markets and Reimbursement to its leadership team. The management appointments coincide with increasing demand for GeneSight pharmacogenomic testing services, which support healthcare providers in medication selection and the management of side effects for patients with neuropsychiatric and other disorders.

"These management appointments provide us with the financial leadership to address the next phase of our growth strategy and the payer market expertise to partner with Medicare, Medicaid, and commercial payers," said James S. Burns , president and CEO of Assurex Health. "Our value proposition is directed to demonstrating significant improvements in patient outcomes at substantial reductions in healthcare utilization. The goal is to build the leading personalized medicine company offering pharmacogenomic treatment decision support solutions for neuropsychiatric, pain, ADHD, and other disorders."

Stephen A. Stamp , Senior Vice President & Chief Financial Officer is responsible for all financial matters at Assurex Health, including financing strategy and implementation, accounting, tax, M&A activities, and government contracting. Stephen joins Assurex Health with 30 years of experience in finance, accounting, business development and operations. He has worked in multiple public and venture-backed companies both in the US and the UK, including business to consumer (B2C), business to business (B2B), and pharmaceutical industries. Stephen has served as Chief Financial Officer of EZCORP, Inc. (NASDAQ: EZPW), a consumer financial services company; Chief Operating Officer, Chief Financial Officer, and Executive Vice President Business Development at Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company; Group Finance Director at Regus PLC, a serviced office accommodations business; and Group Finance Director at Shire PLC, a specialty pharmaceutical company focusing on ADHD and other specialty medications. Earlier in his career, Stephen was an investment banker with Lazard in London, advising mainly public companies on cross-border M&A and corporate finance. Prior to Lazard, he worked for KPMG in London where he qualified as a Chartered Accountant. Stephen received his BA in economics from the University of Manchester.

Jeffrey P. Bush , Vice President of Payer Markets and Reimbursement is responsible for establishing coverage and value-based reimbursement with commercial and governmental payers for Assurex Health products, as well as the Company's overall strategy for collaborating with payers and payer stakeholders. Jeff brings to Assurex Health over twenty years of experience in diagnostics, medical devices, and clinical laboratory testing. Prior to joining Assurex Health, Jeff served as senior director of Reimbursement Strategy & Payment Policy at Becton, Dickinson and Company (BD) (NYSE: BDX), a global medical device and diagnostic system manufacturer, responsible for reimbursement across BD's three worldwide business segments to establish coding, coverage, and payment for the company's products in the US and abroad. While at BD, Jeff was instrumental in the development and passage of reform legislation that enhanced transparency of the Centers for Medicare and Medicaid Services (CMS) processes for the coverage and payment of new diagnostic technologies, and developed quality measurement legislative language included in the Affordable Care Act of 2010. Prior to BD, Jeff led CYTYC Corporation's (now Hologic) efforts with US payers that drove adoption and eventual market dominance of the ThinPrep® Pap Test. Prior to CYTYC, Jeff was employed as a certified cytotechnologist in multiple clinical laboratories. He holds a Bachelor's degree in Chemistry from California State University, San Bernardino, a Cytotechnology certificate from Loma Linda University, and a Master of Business Administration from Colorado State University.

About AssureRx Health, Inc.
AssureRx Health, Inc. is a personalized medicine company that specializes in pharmacogenomics dedicated to helping physicians determine the right drug for individual patients suffering from neuropsychiatric and other disorders. The company was founded to commercialize industry-leading personalized medicine technology for neuropsychiatric disorders. Mayo Clinic and Cincinnati Children's Hospital Medical Center are equity holders and technology collaborators.

About GeneSight
GeneSight is a laboratory developed pharmacogenomic test that uses cutting edge technology to measure and analyze clinically important genomic variants in the treatment of psychiatric disorders. The results of the GeneSight report can help a clinician understand the way a patient's unique genomic makeup may affect certain psychiatric drugs. The analysis is based on pharmacogenomics, the study of genomic factors that influence an individual's response to drug treatments, FDA approved manufacturer's drug labels, peer-reviewed scientific and clinical publications, and proven drug pharmacology. Quick turnaround time, combined with a customized report of the patient's genomic makeup, clinical experience and other factors can help a physician make personalized drug treatment choices for each patient.


'/>"/>
SOURCE AssureRx Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
3. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
4. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
5. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
8. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
9. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
10. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
11. Med Ad News Honors Healthcare Communication Agencies at 23rd Annual Manny Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... , June 16, 2017 Datascope Corp. is voluntarily ... Datascope Corp. for a potential electrical test failure code.     ... PART NUMBER ... IABP CS300 IABP ... ...
(Date:6/14/2017)... June 14, 2017  ivWatch LLC, a medical device ... intravenous (IV) therapy, is pleased to announce it was ... Nonsurgical Hospital Supplies and Equipment at the 2017 Medical ... the medtech industry. The award was presented by Medical ... Javits Center in New York ...
(Date:6/14/2017)... , June 14, 2017  In 2016, ... Creative Startups pitch competition and came away with ... platform is described by Forbes as "entering the life ... Medical Association as teaching "empathy to medical professionals in ... startup was recently named a finalist for the Department ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... 23, 2017 , ... Military Connection friend and veteran advocate Micaela ... Virgin Atlantic lounge. , Bensko is no stranger to the plight of the ... her life to supporting our wounded veterans. A world-class photographer, her riveting photos “The ...
(Date:6/23/2017)... ... ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach to ... technique that he calls the AuraLyft Facelift. The AuraLyft does more than ... expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach stems ...
(Date:6/23/2017)... , ... June 23, 2017 , ... 21 Middle East ... (EF) has selected 21 leaders from government, business and civil society in 11 countries ... the U.S. this fall, engaging in a transformative exchange of knowledge and ideas with ...
(Date:6/23/2017)... ... 2017 , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves ... Agency’s (FEMA) recent update of flood zones, more people than ever are in ... enacted to reflect the actual risk in flood zone areas during a time ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Katyl ... services to families and business owners in and around Lackawanna County, is joining ... citizens in the area. , Meals on Wheels of NEPA provides hand-delivered and ...
Breaking Medicine News(10 mins):